BONDUELLE Head office: “La Woestyne” – 59173 Renescure – FranceBonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 eurosRegistered under number: 447 250 044 (Dunkerque Commercial and Companies Register)2024-2025 Annual results (July 1, 2024 – June 30, 2025) “Transform to win”: The Bonduelle Group achieves its first-year transformation plan objectives and initiates its recovery Message from Xavier Unkovic – Chief Executive Officer: For this 1st year of the “Transform to win” transformation plan, the Bonduelle Group is on track and achieves its revenue and profitability objectives for fiscal year 2024-2025, while continuing its journey towards a B Corp™ certification. These results are driven by the improved performance in the United States, the reorganization...

Villers-lès-Nancy, 26 September 2025 – 6:00 PM (CET) PRESS RELEASE 2025 half-year resultsRevenue: €116.0m (+7.4% reported and +6.4% like-for-like) Recurring EBITDA: €29.8m (+5.5%) Current Operating Profit €21.1m (+1.2%) Net Profit: €18.1m (+0.3%) Net Financial Surplus : €98.8m (+€19.2m / 31-12-2024)H1 2025 RESULTS(M€) 2024Reported basis2025Reported basisChange / Reported basisRevenue 108.0 116.0 8.0 7.4%Recurring EBITDA 28.2 29.8 1.5 5.5%Recurring EBITDA / Sales 26.1% 25.7%    Current operating profit 20.9 21.1 0.2 1.2%COP / Sales 19.3% 18.2%    Net Profit 18.1 18.1 0.0 0.3%Net Profit attributable to the Group 17.2 17.3 0.1 0.4%To facilitate the analysis of performance and comparability with other market players, a new indicator has been introduced, recurring EBITDA defined as current operating...

BEIJING, Sept. 26, 2025 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company” or “We”) (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced its unaudited financial results for the six months ended June 30, 2025. Financial and Operational Highlights for the First Half of 2025Number of followers1 as of June 30, 2025 reached 36.6 million, an increase of 9.9% from 33.3 million as of June 30, 2024.  Total revenues were RMB93.2 million (US$13.0 million) in the first half of 2025, compared to RMB102.4 million in the same period of 2024.  Revenues from online advertising services were RMB74.5 million (US$10.4 million) in the first half of 2025, compared to RMB80.4 million in the same period of 2024.  Revenues from enterprise value-added services were...

AUSTIN, Texas, Sept. 25, 2025 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the fiscal year ended June 30, 2025. Financial Highlights & Fiscal Year Developments Revenue decreased to $1.0 million as Astrotech’s subsidiary, 1st Detect, sold less devices compared to prior year. Gross margin increased to 45.3% for the year compared to 45.1% in the prior year, due to device sales in fiscal year 2025 having a higher margin compared to the device sales in fiscal year 2024.As of June 30, 2025, the Company has deployed the TRACER 1000 in approximately 34 locations in 16 countries across the United States, Europe and Asia.The Company announced the formation of a new wholly owned subsidiary, EN-SCAN, Inc. to manufacture and sell a new line of instruments...

ISSAQUAH, Wash., Sept. 25, 2025 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the 16-week fourth quarter and the 52-week fiscal year ended August 31, 2025. Net sales for the quarter increased 8.0 percent, to $84.4 billion, from $78.2 billion last year. Net sales for the fiscal year increased 8.1 percent, to $269.9 billion, from $249.6 billion last year. Comparable sales for the fourth quarter and fiscal year were as follows:    16 Weeks   16 Weeks   52 Weeks   52 Weeks          Adjusted*       Adjusted*    U.S. 5.1%   6.0%   6.2%   7.3%    Canada 6.3%   8.3%   5.0%   8.3%    Other International 8.6%   7.2%   4.8%   8.2%                       Total Company 5.7%   6.4%   5.9%   7.6%                       E-commerce 13.6%   13.5%   15.6%   16.1%  *Excluding...

Delivers revenue above guidance for Q3 and raises full year growth outlook Sees strong demand environment for integrated solutions On track to return more than $240 million to shareholders in fiscal 2025 Increases quarterly dividendNEWARK, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced financial results for the fiscal third quarter ended August 31, 2025.  Three Months Ended      August 31, 2025   August 31, 2024   ChangeRevenue($M) $ 2,483.3     $ 2,387.4     4.0 %Operating income($M) $ 147.0     $ 153.2     (4.0 )%Non-GAAP operating income($M) (1) $ 305.1     $ 331.0     (7.8 )%Operating margin   5.9 %     6.4 %   -50 bpsNon-GAAP operating margin (1)   12.3 %     13.9 %   -160 bpsNet income($M) $ 88.1     $ 16.6     430.7 %Non-GAAP...

                                                                Charenton-le-Pont, 25 September 2025 H1 2025 earnings First half 2025 earnings down sharply amid difficult commercial negotiations in France with some customers, despite business resilience in certain international regionsEBITDA1 of €5.9m in H1 2025, down €2.6m from €8.5m in H1 2024 80 bps improvement in Gross margin ratio thanks to international business Net profit (Group share) of €2.6m in H1 2025, down €3.9m Continuation and acceleration of the cost reduction programme in the second half of the year in order to safeguard the Group’s profitabilityMarie Brizard Wine & Spirits (the “Company”) (Euronext: MBWS) today announces its consolidated earnings for H1 2025 as approved by the Group’s Board of Directors on 24 September 2025. The audit procedures have been...

OSE Immunotherapeutics Reports its Cash Position as of June 30, 2025 Nantes, France, September 25, 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) reports its cash position as of June 30, 2025. Due to the Company’s Annual General Meeting being rescheduled to September 30, 2025, and to allow shareholders to first approve 2024 financial statements, the full 2025 half-year interim financial results will be published on October 15, 2025. Update on AbbVie Partnership related to ABBV-230 The Company initially expected the initiation of Phase 1 trial of ABBV-230 and the related milestone payment in late 2025. Based on current discussions with its partner, the Company now anticipates a delay in the development timeline. As the Company has no control over the start of this trial, and in line with the principle...

ABC arbitrageRelease of the interim financial report as of June 30, 202 5 ABC arbitrage announces that as of today its financial report for the first half of 2025 has been publicly released and filed with the Autorité des Marchés Financiers (AMF). This document includes the following parts:The half-year management report The consolidated financial statements as of June 30, 2025 The statutory auditors’ report Statement by the person responsible for the financial reportThe annual financial report can be consulted on the Group website at: abc-arbitrage.com, in the “Shareholders” page, heading Financial information / Financial reports.Contacts : abc-arbitrage.comRelations actionnaires : actionnaires@abc-arbitrage.comRelations presse: VERBATEE / v.sabineu@verbatee.com EURONEXT...

     PRESS RELEASEFirst-half financial information as of June 30, 2025IFRS – Regulated information – Not audited Cegedim’s profitability improving as expectedRevenue up 1.1% as reported and 2.8% LFL to €322.5 million Adjusted EBITDA (1) of €61.2 million, equal to 19.0% of revenue Adjusted operating margin(1) of 5.7% vs. 3.2% in 2024Boulogne-Billancourt, France, September 25, 2025, after the market close Cegedim generated consolidated H1 2025 revenue of €322.5 million, a 1.1% year-on-year increase as reported, and adjusted EBITDA(1) of €61.2 million, a €9.0 million or 17.2% increase. Adjusted operating margin(1) came to 5.7% compared with 3.2% in 2024. Adjusted operating income(1) was positive at every division.  H1 2025 H1 2024 Change  In €m In % In €m In % In €m In %Revenue 322.5 100.0% 319.0 100.0% 3.5 1.1%Recurring...